A detailed history of Ae Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ae Wealth Management LLC holds 930,450 shares of PFE stock, worth $24.9 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
930,450
Previous 729,326 27.58%
Holding current value
$24.9 Million
Previous $20.4 Million 31.96%
% of portfolio
0.28%
Previous 0.23%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $5.57 Million - $6.31 Million
201,124 Added 27.58%
930,450 $26.9 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $6.2 Million - $7.27 Million
245,607 Added 50.77%
729,326 $20.4 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $14.2 Million - $16.3 Million
-548,395 Reduced 53.13%
483,719 $13.4 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $9.07 Million - $11.8 Million
-346,942 Reduced 25.16%
1,032,114 $29.7 Million
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $1.47 Million - $1.72 Million
-45,870 Reduced 3.22%
1,379,056 $45.7 Million
Q2 2023

Jul 10, 2023

BUY
$36.12 - $41.79 $17.1 Million - $19.7 Million
472,231 Added 49.57%
1,424,926 $52.3 Million
Q1 2023

Apr 14, 2023

SELL
$39.39 - $51.28 $1.33 Million - $1.74 Million
-33,837 Reduced 3.43%
952,695 $38.9 Million
Q4 2022

Jan 31, 2023

BUY
$41.75 - $54.5 $702,402 - $916,908
16,824 Added 1.73%
986,532 $50.6 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $2.75 Million - $3.35 Million
62,753 Added 6.92%
969,708 $42.4 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $3.55 Million - $4.21 Million
76,400 Added 9.2%
906,955 $47.6 Million
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $987,330 - $1.22 Million
21,581 Added 2.67%
830,555 $43 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $2.23 Million - $3.31 Million
54,027 Added 7.16%
808,974 $47.8 Million
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $1.27 Million - $1.63 Million
32,305 Added 4.47%
754,947 $32.5 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $4.91 Million - $5.56 Million
136,758 Added 23.34%
722,642 $28.3 Million
Q1 2021

Apr 27, 2021

SELL
$33.49 - $37.77 $765,715 - $863,573
-22,864 Reduced 3.76%
585,884 $21.2 Million
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $3.97 Million - $5.05 Million
118,675 Added 24.22%
608,748 $22.4 Million
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $3.59 Million - $4.21 Million
113,106 Added 30.0%
490,073 $18 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $2.95 Million - $3.57 Million
97,799 Added 35.03%
376,967 $12.3 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $801,250 - $1.14 Million
29,643 Added 11.88%
279,168 $9.11 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $1.35 Million - $1.53 Million
41,038 Added 19.68%
249,525 $9.78 Million
Q3 2019

Nov 05, 2019

BUY
$32.49 - $42.13 $15,075 - $19,548
464 Added 0.22%
208,487 $7.49 Million
Q2 2019

Jul 22, 2019

BUY
$36.98 - $41.52 $2.48 Million - $2.79 Million
67,157 Added 47.67%
208,023 $9.01 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $320,737 - $352,383
8,553 Added 6.46%
140,866 $5.98 Million
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $1.08 Million - $1.23 Million
-28,138 Reduced 17.54%
132,313 $5.78 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $2.69 Million - $3.26 Million
77,962 Added 94.51%
160,451 $7.07 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $186,633 - $198,970
-5,659 Reduced 6.42%
82,489 $2.99 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $725,537 - $841,723
22,737 Added 34.76%
88,148 $3.13 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $289,761 - $307,446
-8,712 Reduced 11.75%
65,411 $2.37 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $80,166 - $88,311
2,586 Added 3.61%
74,123 $2.65 Million
Q2 2017

Aug 14, 2017

BUY
N/A
71,537
71,537 $2.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.